175 related articles for article (PubMed ID: 23929317)
1. Risk factors for human herpesvirus 6 reactivation and its relationship with syndrome of inappropriate antidiuretic hormone secretion after stem cell transplantation in pediatric patients.
Toriumi N; Kobayashi R; Yoshida M; Iguchi A; Sarashina T; Okubo H; Suzuki D; Sano H; Ogata M; Azuma H
J Pediatr Hematol Oncol; 2014 Jul; 36(5):379-83. PubMed ID: 23929317
[TBL] [Abstract][Full Text] [Related]
2. Early human herpesvirus type 6 reactivation after allogeneic stem cell transplantation: a large-scale clinical study.
Dulery R; Salleron J; Dewilde A; Rossignol J; Boyle EM; Gay J; de Berranger E; Coiteux V; Jouet JP; Duhamel A; Yakoub-Agha I
Biol Blood Marrow Transplant; 2012 Jul; 18(7):1080-9. PubMed ID: 22212513
[TBL] [Abstract][Full Text] [Related]
3. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome.
de Pagter PJ; Schuurman R; Visscher H; de Vos M; Bierings M; van Loon AM; Uiterwaal CS; van Baarle D; Sanders EA; Boelens J
Biol Blood Marrow Transplant; 2008 Jul; 14(7):831-9. PubMed ID: 18541204
[TBL] [Abstract][Full Text] [Related]
4. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.
Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K
Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656
[TBL] [Abstract][Full Text] [Related]
5. Human herpes virus 6 reactivation: important predictor for poor outcome after myeloablative, but not non-myeloablative allo-SCT.
de Pagter PJ; Schuurman R; Keukens L; Schutten M; Cornelissen JJ; van Baarle D; Fries E; Sanders EA; Minnema MC; van der Holt BR; Meijer E; Boelens JJ
Bone Marrow Transplant; 2013 Nov; 48(11):1460-4. PubMed ID: 23771003
[TBL] [Abstract][Full Text] [Related]
6. First analysis of human herpesvirus 6T-cell responses: specific boosting after HHV6 reactivation in stem cell transplantation recipients.
de Pagter AP; Boelens JJ; Scherrenburg J; Vroom-de Blank T; Tesselaar K; Nanlohy N; Sanders EA; Schuurman R; van Baarle D
Clin Immunol; 2012 Sep; 144(3):179-89. PubMed ID: 22820131
[TBL] [Abstract][Full Text] [Related]
7. Hyponatremia and syndrome of inappropriate antidiuretic hormone secretion complicating stem cell transplantation.
Kobayashi R; Iguchi A; Nakajima M; Sato T; Yoshida M; Kaneda M; Suzuki Y; Mino E; Kuroki F; Kobayashi K
Bone Marrow Transplant; 2004 Dec; 34(11):975-9. PubMed ID: 15448660
[TBL] [Abstract][Full Text] [Related]
8. Long-term prognosis of human herpesvirus 6 reactivation following allogeneic hematopoietic stem cell transplantation.
Iesato K; Hori T; Yoto Y; Yamamoto M; Inazawa N; Kamo K; Ikeda H; Iyama S; Hatakeyama N; Iguchi A; Sugita J; Kobayashi R; Suzuki N; Tsutsumi H
Pediatr Int; 2018 Jun; 60(6):547-552. PubMed ID: 29542206
[TBL] [Abstract][Full Text] [Related]
9. Human herpesvirus-6 encephalopathy after hematopoietic stem cell transplantation and class I human leukocyte antigen.
Yamamoto W; Ogusa E; Matsumoto K; Maruta A; Ishigatsubo Y; Kanamori H
Clin Transplant; 2014 May; 28(5):540-5. PubMed ID: 24579822
[TBL] [Abstract][Full Text] [Related]
10. Severe hyponatremia caused by syndrome of inappropriate secretion of antidiuretic hormone developed as initial manifestation of human herpesvirus-6-associated acute limbic encephalitis after unrelated bone marrow transplantation.
Kawaguchi T; Takeuchi M; Kawajiri C; Abe D; Nagao Y; Yamazaki A; Sugita Y; Tsukamoto S; Sakai S; Takeda Y; Ohwada C; Sakaida E; Shimizu N; Yokote K; Iseki T; Nakaseko C
Transpl Infect Dis; 2013 Apr; 15(2):E54-7. PubMed ID: 23173742
[TBL] [Abstract][Full Text] [Related]
11. Human herpesvirus 6 reactivation before engraftment is strongly predictive of graft failure after double umbilical cord blood allogeneic stem cell transplantation in adults.
Le Bourgeois A; Labopin M; Guillaume T; Delaunay J; Foucher Y; Tessoulin B; Malard F; Ayari S; Peterlin P; Derenne S; Herry P; Cesbron A; Gagne K; Lodé L; Illiaquer M; Imbert-Marcille BM; Le Gouill S; Moreau P; Mohty M; Chevallier P
Exp Hematol; 2014 Nov; 42(11):945-54. PubMed ID: 25072620
[TBL] [Abstract][Full Text] [Related]
12. Human herpesvirus 6 (HHV6) DNA persistence and reactivation in healthy children.
Caserta MT; McDermott MP; Dewhurst S; Schnabel K; Carnahan JA; Gilbert L; Lathan G; Lofthus GK; Hall CB
J Pediatr; 2004 Oct; 145(4):478-84. PubMed ID: 15480370
[TBL] [Abstract][Full Text] [Related]
13. Reactivation of Human Herpes Virus-6 After Pediatric Stem Cell Transplantation: Risk Factors, Onset, Clinical Symptoms and Association With Severity of Acute Graft-Versus-Host Disease.
Verhoeven DH; Claas EC; Jol-van der Zijde CM; Thijssen JC; Lankester AC; Bredius RG; Putter H; Kroes AC; Egeler RM; Schilham MW; van Tol MJ
Pediatr Infect Dis J; 2015 Oct; 34(10):1118-27. PubMed ID: 26132825
[TBL] [Abstract][Full Text] [Related]
14. Prospective, comprehensive, and effective viral monitoring in children undergoing allogeneic hematopoietic stem cell transplantation.
Schönberger S; Meisel R; Adams O; Pufal Y; Laws HJ; Enczmann J; Dilloo D
Biol Blood Marrow Transplant; 2010 Oct; 16(10):1428-35. PubMed ID: 20399877
[TBL] [Abstract][Full Text] [Related]
15. Occupational trichloroethylene hypersensitivity syndrome: human herpesvirus 6 reactivation and rash phenotypes.
Kamijima M; Wang H; Yamanoshita O; Ito Y; Xia L; Yanagiba Y; Chen C; Okamura A; Huang Z; Qiu X; Song X; Cai T; Liu L; Ge Y; Deng Y; Naito H; Yoshikawa T; Tohyama M; Li L; Huang H; Nakajima T
J Dermatol Sci; 2013 Dec; 72(3):218-24. PubMed ID: 23928230
[TBL] [Abstract][Full Text] [Related]
16. The syndrome of inappropriate secretion of antidiuretic hormone associated with SCT: clinical differences following SCT using cord blood and BM/peripheral blood.
Suzuki Y; Kobayashi R; Iguchi A; Sato T; Kaneda M; Kobayashi K; Ariga T
Bone Marrow Transplant; 2008 Dec; 42(11):743-8. PubMed ID: 18711342
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus reactivation in allogeneic stem cell transplantation is highly related to cytomegalovirus reactivation.
Zallio F; Primon V; Tamiazzo S; Pini M; Baraldi A; Corsetti MT; Gotta F; Bertassello C; Salvi F; Rocchetti A; Levis A
Clin Transplant; 2013; 27(4):E491-7. PubMed ID: 23781897
[TBL] [Abstract][Full Text] [Related]
18. Human herpes virus 6 infection is a hallmark of cord blood transplant in adults and may participate to delayed engraftment: a comparison with matched unrelated donors as stem cell source.
Chevallier P; Hebia-Fellah I; Planche L; Guillaume T; Bressolette-Bodin C; Coste-Burel M; Rialland F; Mohty M; Imbert-Marcille BM
Bone Marrow Transplant; 2010 Jul; 45(7):1204-11. PubMed ID: 19935727
[TBL] [Abstract][Full Text] [Related]
19. Relationship among human herpesvirus 6 reactivation, serum interleukin 10 levels, and rash/graft-versus-host disease after allogeneic stem cell transplantation.
Kitamura K; Asada H; Iida H; Fukumoto T; Kobayashi N; Niizeki H; Morii T; Kimura H; Miyagawa S
J Am Acad Dermatol; 2008 May; 58(5):802-9. PubMed ID: 18367292
[TBL] [Abstract][Full Text] [Related]
20. Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: a multicenter, prospective study.
Ogata M; Satou T; Kadota J; Saito N; Yoshida T; Okumura H; Ueki T; Nagafuji K; Kako S; Uoshima N; Tsudo M; Itamura H; Fukuda T
Clin Infect Dis; 2013 Sep; 57(5):671-81. PubMed ID: 23723198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
